* Says test can detect Influenza A&B, RSV A&B, H1N1
* Shares up 19 pct
Jan 13 (Reuters) - Nanosphere Inc NSPH.O said U.S. health regulators approved its test to detect respiratory viruses, sending the company’s shares up as much as 19 percent.
Nanosphere, which makes diagnostic devices, said its Verigene system can detect Influenza A, Influenza B, respiratory syncytial virus A (RSV A), and RSV B, and Influenza A subtypes like H1, H3, or 2009 H1N1.
Nanosphere shares, which have gained 46 percent since the company settled a patent lawsuit in August, were up 8 percent at $4.82 on Thursday on Nasdaq. They earlier touched a high of $5.54. (Reporting by Anand Basu in Bangalore; Editing by Vyas Mohan)